{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:50:49Z","timestamp":1762505449710},"reference-count":11,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2009,1,2]],"date-time":"2009-01-02T00:00:00Z","timestamp":1230854400000},"content-version":"vor","delay-in-days":398,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Laryngoscope"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Objectives\/Hypothesis:<\/jats:bold> This study investigated the otoprotective properties of AM\u2010111, an inhibitor of c\u2010Jun N\u2010terminal kinase\u2010mediated apoptosis and inflammation.<\/jats:p><jats:p><jats:bold>Study Design:<\/jats:bold> A controlled, prospective animal study using a guinea pig model of acute labyrinthitis.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Acute labyrinthitis was generated by injection of antigen into the scala tympani of sensitized guinea pigs. Treatment groups received 100 \u03bcL of AM\u2010111 at concentrations of 100 \u03bcmol\/L, 10 \u03bcmol\/L, and 1 \u03bcmol\/L in a hyaluronic acid gel formulation delivered over the round window niche within 1 hour of antigen challenge. Cochlear function was monitored over 21 days with serial auditory brainstem response (ABR) and distortion product otoacoustic emission (DPOAE) measurements followed by histologic analysis.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The ABR results on day 21 demonstrated that untreated control ears for acute labyrinthitis had a mean hearing loss (HL) of 68 \u00b1 12 dB. In contrast, ears treated with AM\u2010111 (100 \u03bcmol\/L) had a mean HL of 39 \u00b1 31 dB. These two groups were statistically different (one\u2010way analysis of variance, <jats:italic>P<\/jats:italic> = .03). Secondary outcomes, including DPOAE shift, inner hair cell survival, inflammatory cell counts, and spiral ganglion density, were also statistically significant in favor of an otoprotective effect of AM\u2010111. Lower doses of AM\u2010111 did not produce a statistically significant reduction in HL over controls.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> AM\u2010111 delivered over the round window membrane in a 100 \u03bcL hyaluronic acid formulation at a 100 \u03bcmol\/L concentration immediately after induction of acute labyrinthitis in the guinea pig cochlea protects hearing, reduces hair cell loss, and reduces the number of inflammatory cells at 21 days after treatment.<\/jats:p>","DOI":"10.1097\/mlg.0b013e3181461f92","type":"journal-article","created":{"date-parts":[[2009,2,19]],"date-time":"2009-02-19T20:59:58Z","timestamp":1235077198000},"page":"2174-2182","source":"Crossref","is-referenced-by-count":35,"title":["AM\u2010111 Reduces Hearing Loss in a Guinea Pig Model of Acute Labyrinthitis"],"prefix":"10.1002","volume":"117","author":[{"given":"Gregory C.","family":"Barkdull","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yannick","family":"Hondarrague","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey P.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth M.","family":"Keithley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,1,2]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-200209000-00019"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1132"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.23-24-08596.2003"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.heares.2006.05.006"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.106.028936"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.heares.2006.09.008"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00129492-200501000-00005"},{"key":"e_1_2_7_9_2","unstructured":"RasbandWS ImageJ. Bethesda MD. US National Institutes of Health. Available at:http:\/\/rsb.info.nih.gov\/ij\/. Accessed December 28 2006."},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-200003000-00024"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-996893"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1006\/mthe.2000.0129"}],"container-title":["The Laryngoscope"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1097%2FMLG.0b013e3181461f92","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1097\/MLG.0b013e3181461f92","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T03:59:41Z","timestamp":1696910381000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1097\/MLG.0b013e3181461f92"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":11,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["10.1097\/MLG.0b013e3181461f92"],"URL":"https:\/\/doi.org\/10.1097\/mlg.0b013e3181461f92","archive":["Portico"],"relation":{},"ISSN":["0023-852X","1531-4995"],"issn-type":[{"value":"0023-852X","type":"print"},{"value":"1531-4995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}